Susquehanna International Group, LLP Immunovant, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2024

A detailed history of Susquehanna International Group, LLP transactions in Immunovant, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 243,643 shares of IMVT stock, worth $6.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

243,643

Previous 198,712 22.61%

Holding current value

$6.7 Million

Previous $8.37 Million 5.96%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$30.27 - $43.79 $1.36 Million - $1.97 Million	44,931 Added 22.61%	243,643 $7.87 Million
Q4 2023 Feb 14, 2024	BUY	$31.31 - $44.19 $2.58 Million - $3.64 Million	82,376 Added 70.81%	198,712 $8.37 Million
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $1.83 Million - $3.94 Million	98,521 Added 553.02%	116,336 $4.47 Million
Q2 2023 Aug 11, 2023	SELL	$14.2 - $23.75 $1.76 Million - $2.95 Million	-124,214 Reduced 87.46%	17,815 $337,000
Q1 2023 May 16, 2023	BUY	$15.27 - $19.72 $1.84 Million - $2.38 Million	120,780 Added 568.4%	142,029 $2.2 Million

Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $55,257 - $148,833	8,385 Added 65.18%	21,249 $377,000
Q3 2022 Nov 14, 2022	SELL	$3.93 - $6.37 $29,687 - $48,118	-7,554 Reduced 37.0%	12,864 $72,000
Q2 2022 Aug 15, 2022	SELL	$3.38 - $5.65 $219,405 - $366,758	-64,913 Reduced 76.07%	20,418 $80,000
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $448,720 - $777,723	-88,680 Reduced 50.96%	85,331 $470,000
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $624,310 - $793,803	-85,172 Reduced 32.86%	174,011 $1.48 Million
Q3 2021 Nov 15, 2021	BUY	$7.01 - $11.37 $65,978 - $107,014	9,412 Added 3.77%	259,183 $2.25 Million
Q2 2021 Aug 11, 2021	BUY	$9.4 - $16.85 $1.95 Million - $3.49 Million	207,373 Added 489.11%	249,771 $2.64 Million
Q1 2021 May 17, 2021	BUY	$13.08 - $49.6 $327,562 - $1.24 Million	25,043 Added 144.3%	42,398 $680,000
Q4 2020 Feb 16, 2021	SELL	$36.36 - $52.71 $8,980 - $13,019	-247 Reduced 1.4%	17,355 $802,000
Q3 2020 Nov 16, 2020	BUY	$22.61 - $38.9 $397,981 - $684,717	17,602 New	17,602 $619,000

Others Institutions Holding IMVT

# of Institutions

240

Shares Held

63.1M

Call Options Held

1.46M

Put Options Held

546K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Immunovant, Inc. Transaction History